Moneycontrol PRO
LAMF
LAMF

Merck

Jump to
  • Merck, Linde eye India for semiconductor-grade chemical, gas facilities: Report

    Semiconductor production relies on over 150 chemicals and more than 30 gases and minerals, with their quality and reliability playing a crucial role in the success of the manufacturing process.

  • Merck in pact for Chinese obesity drug in nearly $2 billion deal

    Under the terms of the deal, Hansoh Pharma would also receive royalties on sales, and may co-promote or solely commercialize the drug in China subject to certain conditions, the companies said in the statement.

  • Pharma giant Merck acquires Prometheus for nearly $11 billion: Report

  • Delhi hospital, Merck partner to improve access to head & neck, colorectal cancer care

  • Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate

  • Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead

  • Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead

  • Molnupiravir more effective against Omicron, claims new study

  • Covid-19 | Molnupiravir shows more gains than risks, say experts

  • FDA panel backs first-of-a-kind COVID-19 pill from Merck

  • COVID-19: Is the hype around the oral drug Molnupiravir justified?

  • Explained | Pfizer v/s Merck: New anti COVID pill and its comparison

  • New COVID-19 pill cut hospital, death risk by 90%, says Pfizer

  • EU medicines agency starts review of Merck oral COVID drug

  • Merck asks US regulators to authorize promising anti-COVID pill

  • Merck’s COVID-19 drug can be a game-changer

  • Merck spends $11.5 billion for Acceleron, possible blockbuster drug

  • Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO

  • Ideas for profit | Lupin: Focus on inhalation & biosimilars to aid margins in medium term

  • Lupin: Focus on inhalation and bio-similars to aid margins in medium term

  • Merck says study shows COVID-19 drug causes quick reduction in virus

  • Merck to help produce J&J's COVID-19 vaccine

  • Coronavirus Vaccine | How Merck, a vaccine titan, lost the COVID race

  • Merck CEO Kenneth Frazier to retire on June 30; CFO Robert Davis to be new chief

  • US giant Merck stops development of two COVID-19 vaccine candidates

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347